E. Klein

N-Arylsulfonyl-α-amino carboxamides are potent and selective inhibitors of the chemokine receptor CCR10 that show efficacy in the murine DNFB model of contact hypersensitivity.

D. Jeanfavre, N. Moss, Jiang-Ping Wu, 2016, Bioorganic & medicinal chemistry letters.

Therapeutic Blockade of Immune Complex-Mediated Glomerulonephritis by Highly Selective Inhibition of Bruton’s Tyrosine Kinase

C. Putterman, E. Der, L. Herlitz, 2016, Scientific Reports.

Safety, pharmacokinetics and pharmacodynamics of BI 705564, a highly selective, covalent inhibitor of Bruton's tyrosine kinase, in Phase I clinical trials in healthy volunteers

F. Müller, S. Visvanathan, S. Wiebe, 2020, British journal of clinical pharmacology.

BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.

C. Putterman, L. Herlitz, G. Nabozny, 2018, Clinical immunology.

Highly selective inhibition of Bruton’s tyrosine kinase attenuates skin and brain disease in murine lupus

C. Putterman, H. Perlman, G. Nabozny, 2018, Arthritis Research & Therapy.

BTK inhibition modulates multiple immune cell populations involved in the pathogenesis of immune mediated nephritis.

C. Putterman, L. Herlitz, J. Fine, 2020, Clinical immunology.